Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02630121 · ClinicalTrials.gov registry record · Phase 4

Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea

A Phase 4 study of Sleep Apnea and Chronic Nasal Congestion, sponsored by University of South Florida.

Recruiting
Registry status
Phase 4
Development phase
52
Enrollment target
1
Study location

NCT02630121 is a Phase 4 study of Sleep Apnea and Chronic Nasal Congestion that is actively recruiting participants, run by University of South Florida. The registered enrollment target is 52 participants, below the 2,988-participant average among 36 other Sleep Apnea trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02630121, a Phase 4 study of Sleep Apnea and Chronic Nasal Congestion, is actively recruiting participants, sponsored by University of South Florida.

RECRUITING
Registry status
Phase 4
Development phase
52 participants
Enrollment target
1
Study location

Study Summary

The addition of intranasal oxymetazoline for two weeks to already instituted optimal doses of intranasal fluticasone propionate will decrease the total number of obstructive apneas and hypopneas per hour of sleep in subjects with perennial allergic or non-allergic rhinitis and mild obstructive sleep apnea who have persistent nasal congestion despite maximum doses of NGCS.

Conditions Studied

Sleep Apnea Chronic Nasal Congestion

Interventions

  • DRUG Placebo
  • DRUG Oxymetazoline Hydrochloride

Study Locations (1)

Florida

  • Usf Asthma Allergy and Immunology Cru - Tampa

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2023-04-01
Est. Completion 2026-04
Phase Phase 4

Sponsor

University of South Florida

252 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02630121

The ClinicalTrials.gov registry entry for NCT02630121 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,988-participant average among 36 other Sleep Apnea trials with a reported enrollment target (98% lower). The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Sleep Apnea appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02630121 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02630121 about?

NCT02630121 is a clinical study titled "Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea". The addition of intranasal oxymetazoline for two weeks to already instituted optimal doses of intranasal fluticasone propionate will decrease the total number of obstructive apneas and hypopneas per hour of sleep in subjects with perennial allergic or non-allergic rhinitis and mild obstructive sleep...

What is the current status of trial NCT02630121?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 52 participants. The study started on 2023-04-01. Estimated completion is 2026-04.

What conditions does trial NCT02630121 study?

This clinical trial studies the following conditions: Sleep Apnea, Chronic Nasal Congestion.

What interventions are being tested in trial NCT02630121?

The interventions under investigation include: Placebo (DRUG), Oxymetazoline Hydrochloride (DRUG).

Who is sponsoring clinical trial NCT02630121?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02630121 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Sleep Apnea

All registered trials for this condition

Chronic Nasal Congestion

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.